Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression

  • 1, 2,
  • 1,
  • 2,
  • 3, 4,
  • 3, 4,
  • 3, 4,
  • 2,
  • 5,
  • 6,
  • 1, 7Email author and
  • 1Email author
Molecular Brain201710:48

https://doi.org/10.1186/s13041-017-0327-6

  • Received: 25 September 2017
  • Accepted: 25 September 2017
  • Published:

The original article was published in Molecular Brain 2015 8:54

Correction to: Molecular brain (2015) 8:54 DOI 10.1186/s13041-015-0145-7

In the original publication of this article [1], published on 18 September 2015, it was noticed that the information on a plasmid expressing HA-tagged human p53 gene is wrong. In this Correction the incorrect and correct information on this gene are shown (and marked bold).

In the first paragraph of the Methods section, the plasmid expressing HA-tagged human p53 gene is described as followed:

Plasmids expressing the HA-tagged human p53 gene (16434) and FLAG-p21 (16240) were purchased from Addgene (Cambridge, MA, USA) and shLRRK2 plasmid specifically inhibiting expression of endogenous human LRRK2 (TI202451) from ORIGENE (Rockville, MD, USA).

The correct description of the plasmid expressing HA-tagged human p53 gene is:

Ha-p53 WT was previously described [2]. FLAG-p21 was purchased from Addgene (#16240, Cambridge, MA, USA) and shLRRK2 plasmid specifically inhibiting expression of endogenous human LRRK2 (TI202451) from ORIGENE (Rockville, MD, USA).

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
InAm Neuroscience Research Center, Sanbon Medical Center, College of Medicine, Wonkwang University, 321 Sanbon-ro, Gunposhi, Gyeonggido, Republic of Korea
(2)
Department of Molecular and Life Sciences, Hanyang University, Ansanshi, Gyeonggido, Republic of Korea
(3)
Stem Cell Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, Republic of Korea
(4)
Korea University of Science & Technology (UST), 113 Gwahak-ro, Yuseong-gu, Daejeon, Republic of Korea
(5)
Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seodaemun-gu, Seoul, Republic of Korea
(6)
Department of Molecular Biology, College of Natural Science, Pusan National University, Pusan, Republic of Korea
(7)
Department of Neurology, Sanbon Medical Center, College of Medicine, Wonkwang University, 321 Sanbon-ro, Gunposhi, Gyeonggido, Republic of Korea

References

  1. Ho, et al. Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression. Molecular Brain. 2015;8:54. doi:10.1186/s13041-015-0145-7.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Cho J-H, Lee S-J, Ah-Young O, Yoon M-H, Woo T-G, Park B-J. NF2 blocks Snail-mediated p53 suppression in mesotheliomam. Oncotarget. 2015;6:10073–85.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

Advertisement